Purpose: The National Institute of Clinical Excellence (NICE) has published evidence-based guidance on assessing and reducing the risk of venous thromboembolism (VTE). Despite this, practice and compliance are variable. We report a complete audit cycle, which quantified compliance and then implemented measures to improve compliance to NICE guidelines in Wycombe Hospital (district general hospital, Oxfordshire) Urology Department.
Introduction
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolus (PE), is a common and potentially fatal post-operative complication. Approximately 15-40% of patients undergoing major urological surgery without VTE prophylaxis develop a DVT post-operatively [1] . Often asymptomatic initially, a DVT can extend proximally and embolise to cause a PE, which accounts for 5-10% of hospital deaths in medicine and surgery each year [2, 3] . Despite this, a UK survey in 2005 identified that fewer than 30% of inpatients at medium or high risk of developing venous thromboembolism were given prophylaxis [4] . Following this survey, in 2010, the National Institute of Clinical Excellence (NICE) published evidence-based guidance summarising the need for individual risk assessment and provision of thromboprophylaxis for all hospitalised patients (Table 1 ) [5] . In developing the final guidance, NICE systematically analysed numerous randomised controlled trials (RCTs), systematic reviews, clinical registries and cohort studies (too numerous to reference here) in order to develop evidence-based recommendations. It was noted that subclinical DVT and PE were common, whilst it was much rarer to encounter clinically detectable thromboembolism; the true incidence of all VTEs is still unknown. Therefore, assessment of VTE risk followed by active prevention was recommended as the most effective way to tackle the clinical problem of VTE. According to the evidence quantitatively assessed by NICE, a list of risk factors for VTE was produced to facilitate stratification of risk in each patient (Table 2 ). During the process of guideline development, it was noted that bleeding risk should also be considered prior to offering pharmacological prophylaxis. Similarly, it is recommended that any contraindications to mechanical prophylaxis are identified before offering this treatment. Then to reduce VTE risk, NICE recommends the use of mechanical and pharmacological agents (See Table 1 ), including lower limb compression devices and low molecular weight heparins. Review of 146 RTCs conducted on patients undergoing abdominal or thoracic surgery found mechanical and pharmacological measures of prophylaxis to be effective with a low incidence of related clinically significant bleeding [5] . Other measures, including optimal mobilisation and hydration, were also highlighted as preventative strategies. Healthcare trusts have subsequently developed individual strategies to address VTE prevention and clinical audit of concordance with NICE guidelines and Trust policy is encouraged. This audit addressed guideline compliance among urology inpatients in a district general hospital. This cohort of patients includes a large number who undergo surgery (either open pelvic surgery or renal tract surgery), which adds to the pre-existing individual patient risk factors for developing a DVT or PE. As a study outcome, guideline compliance is a more appropriate measure for a smaller patient group than the incidence of clinically diagnosed DVT or PE. Therefore, the objectives of this audit were: (i) to assess compliance to VTE risk assessment, (ii) to assess the compliance to thromboembolic prophylaxis prescription and (iii) to identify and implement solutions. 
Methods

Cycle-1:
As a retrospective audit, we examined the notes of 50 adult inpatients consecutively discharged from the Urology Ward at Wycombe Hospital (district general hospital in Oxfordshire) over 2 months (February to March 2011). A sample size of 50 was calculated using the Raosoft online sample size calculator (www.raosoft.com/samplesize.html) based on a population size of 300 (urology admissions per year), 90% confidence level, 10% error and 30% response distribution based upon the 2005 UK survey [4] . Data were obtained from the electronic and paper case-notes. Patients were excluded from data collection if: (i) their hospital stay lasted less than 24 hours (e.g. patients attending for trial without catheter clinics who were not formally admitted, or patients attending for daycase procedures for which the trust uses separate guidelines); or (ii) they were under the care of a non-urological team. During the first cycle, there were 2 exclusions (due to duplication and patient under care of non-urological team), leaving a total sample of 48 patients. Twentytwo different variables were extracted using a standardised audit proforma (Appendix 1). Documented evidence of a VTE risk assessment was recorded as either present or absent. The outcome of the risk assessment (or, where no risk assessment was present, the outcome of a retrospective assessment completed using the information available in the clinical notes) was also recorded. This outcome determined the VTE prophylaxis that should have been prescribed, which was compared to the prophylaxis that had actually been prescribed. Each inpatient stay was then graded as: (1) Fully compliant; (2) Partially compliant; or (3) Non compliant with NICE guidelines (Table 3) .
Statistical analysis:
Data was tabulated and calculations performed using Microsoft Office Excel 2011 (Microsoft, Redmond, Washington). All discrete variables were analysed using Pearson"s Chi-squared test, with statistical significance being set at p < 0.05.
Interventions:
After evaluation of the results, three targeted interventions were made. These were:
1) An integrated urology emergency admission clerking proforma (UAP), containing a VTE risk assessment form and guidance (Appendix 2); 2) Education of doctors at clinical governance, including a presentation and multidisciplinary team discussion of what constituted "routine" prophylaxis for urology patients with subsequent creation of a poster to display this information (Appendix 3); and 3) Incorporation of formal thromboembolic prophylaxis training into junior doctor induction, by way of written material.
Cycle-2:
After 6 months (after a new rotation of junior doctors had received induction), between September and October 2011, a re-audit was performed using identical methodology to Cycle-1. After an exclusion (duplication), the total sample consisted of 49 patients in Cycle-2. [6] .
Results
Forty-eight urology patients were audited in Cycle-1 and, following interventions, 49 patients audited in Cycle-2. The demographics and presenting complaints of the patients sampled in each cycle were not substantially different across the 2 groups (Table 4 ; Figure 1 ). There were a larger proportion of emergency admissions in Cycle-2 and slightly fewer operations performed in Cycle-2, but the difference was not statistically significant. There were 20 admissions with a known urological cancer in Cycle-1, in comparison to 12 patients with a known urological cancer in Cycle-2; the biggest difference was in the rate of prostate cancer diagnoses between the 2 cycles. The mean number of risk factors for VTE in Cycle-1 was 2.2 (range: 0-6), and in Cycle-2 was 2.0 (range: 0-4).
Cycle-1:
Full compliance with NICE guidelines was achieved in only 10% of the 48 admissions audited in Cycle-1 ( Figure 2 ). Twenty-one percent were partially compliant, with suitable prophylaxis prescribed but no documented VTE risk assessment. However the majority (69%) of admissions did not have suitable prophylaxis prescribed despite the presence of risk factors for VTE. To identify specific areas for improvement, the data from Cycle-1 were analysed by variable. Most demographic variables (including patient age, gender, length of stay, and consultant) did not show a significant association with guideline compliance on Chi-squared testing, although there was a trend towards greater levels of guideline compliance with increasing length of hospital stay. However, elective admissions were significantly more likely than emergency admissions to have been VTE risk assessed (85% and 6% respectively were risk assessed; after Chi-squared analysis p<0.05; Table 5 ). Furthermore, patients undergoing major surgery for urological cancer were significantly less likely than the remaining patient sample to have been prescribed guideline-compliant thromboprophylaxis (0% and 35% respectively; after Chi-squared analysis p=0.047; see Table 5 ). The underlying reason(s) for the two significant areas of noncompliance were identified in order to target our interventions. Elective admissions were far more likely to be VTE risk assessed than emergency admissions because the clinical staff performing "preassessment" prior to elective operations had been asked to complete a pre-assessment booklet containing a VTE risk assessment table. The first intervention was therefore an integrated urology emergency admission clerking proforma (UAP), containing a VTE risk assessment form, to be used for all emergency admissions (Appendix 2). All patients in Cycle-1 undergoing major cancer surgery had been non-compliant because they were not prescribed a full 28 days of prophylaxis as per NICE guidelines. This section of NICE guidance was relatively new and therefore less well known. The second intervention was therefore education of doctors at clinical governance to highlight the NICE guidelines and creation of a poster displaying suitable "routine" prophylaxis for each patient group, as agreed at a multidisciplinary team meeting (Appendix 3). Finally, to address the maintenance of interventions 1 and 2, formal guidance and thromboembolic prophylaxis training was incorporated into junior doctor induction as a third intervention.
Cycle-2:
At re-audit 6 months later, full compliance with NICE guidelines had improved to 65% (from 10% in Cycle-1; Figure 2 ). The percentage of inpatient admissions that were partially or fully compliant with NICE guidelines had risen to 83%. Emergency admissions were no longer significantly less likely to have been VTE risk assessed (p=0.59), with 87% of elective admissions and 73% of emergency admissions having been risk assessed in Cycle-2. All patients undergoing major cancer surgery in Cycle-2 had been risk assessed and received appropriate thromboprophylaxis for a full 28 days, as per guidelines. Elective admissions were significantly more likely than emergency admissions to have been VTE risk assessed (84% and 6% respectively; p = 0.00084, Chi-squared). Patients undergoing major surgery for urological cancer were significantly less likely than other patients to have received the correct prophylaxis (0% and 35% respectively; p = 0.047, Chi-squared)
Discussion
Venous thromboembolism is a common and potentially fatal postoperative complication, but one with the potential to be prevented with the use of appropriate prophylaxis. In 2010 NICE published evidencebased guideline summarising the need for individual risk assessment before the use of simple, mechanical and pharmacological prophylaxis for VTE prevention. It is therefore important to devise robust mechanisms by which all hospital inpatients are assessed for VTE risk and prescribed thromboprophylaxis to avoid the morbidity and mortality associated with VTE. This complete audit cycle sampled a spectrum of urology inpatients in a district general hospital. Across the entire sample there was an average of 2 risk factors for VTE per patient. In prevention of thromboembolism, it is vital that each of these patients is carefully risk assessed and prescribed adequate thromboprophylaxis. This audit investigated compliance with NICE guidelines on VTE prevention in this patient group. In the first cycle only 1 in 10 patients had been both VTE risk assessed and prescribed thromboprophylaxis as recommended by NICE. We demonstrated a poor awareness of recent recommendations made by NICE in our hospital. The significant areas of weakness identified were a lack of documented risk assessment for patients admitted non-electively and a lack of awareness of the need for a 28 day course of prophylaxis for patients that had undergone major cancer surgery in the abdomen and pelvis. The findings here highlight that different strategies for ensuring VTE risk assessment completion need to be employed for different admission pathways. It is also clear that the strategies in place must be regularly reviewed in light of new guidance published to maintain up-to-date practice.
Passive measures, such as clinical meetings or distribution of educational materials, are not recommended as lone strategies to improve guideline adherence [1] . Interventions known to improve thromboprophylaxis adherence include computer decision support systems, pre-printed orders, periodic audit and feedback [1] . The main intervention in this audit was a pre-printed proforma (UAP) for use in clerking patients at admission. UAPs were launched with accompanying educational meetings and provision of doctors" induction materials. This combination of interventions was successful in increasing full guideline compliance from 10% to 65%. Junior doctors found the UAP particularly useful because it guided a thorough assessment of urological admissions as well as prompting VTE risk assessment. Its strengths include ease of use and clarity. This proforma has the scope to be amended in light of new guidance, for example the recently released 9 th edition of the ACCP evidencebased recommendations [7] . It could also be employed to achieve further improvements in other areas of urological patient assessment. Limitations of this audit include the small study population and therefore lack of power to demonstrate meaningful change in VTE events. We were unable to show, for example, any changes in the rate of clinically diagnosed VTE after our interventions. Due to the small study population, the number of patients undergoing a major cancer operation was also particularly small in Cycle-2. It is possible that some of the analyses were underpowered and therefore did not reveal significant associations which could have aided us in improving guideline compliance. We were also unable to control all variables between Cycle-1 and Cycle-2, for example, different junior doctors were present during each cycle. With 3 different interventions it becomes unclear which strategy was the most effective in improving adherence to guidelines, although it has been shown that pre-printed proformas are often superior to education or written material [1] .
Conclusions
In conclusion, this complete audit cycle demonstrated an improvement in compliance with guidelines on VTE risk assessment and thromboprophylaxis prescription after the introduction of an integrated UAP form and education package. The UAP may also be a useful tool for implementing future improvements to urological practice.
Conflict of interests:
There is no conflict of interest in this study. 
